| Titolo |
Pubblicato in |
Anno |
| Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| New Insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
| Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
| Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
| A Mobile App-based Approach in Cardiovascular Disease Prevention: A Prospective Randomized Study |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset |
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
2024 |
| Hypertension and Heart Failure: From Pathophysiology to Treatment |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
| Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases |
JOURNAL OF HYPERTENSION |
2024 |
| Position statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on cardiac rehabilitation and protection programs as a cornerstone of secondary prevention after myocardial infarction or revascularization |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| Update on obesity and cardiovascular risk: from pathophysiology to clinical management |
NUTRIENTS |
2024 |
| Chronotropic incompetence across heart failure categories |
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
2024 |
| New insight in cardiorenal syndrome: from biomarkers to therapy |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure |
CELLULAR AND MOLECULAR LIFE SCIENCES |
2023 |
| Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2023 |
| Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals |
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES |
2023 |
| Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension |
MOLECULAR MEDICINE |
2023 |
| Effects of two-month treatment with a mixture of natural activators of autophagy on oxidative stress and arterial stiffness in patients with essential hypertension: A pilot study |
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES |
2023 |
| From cardiovascular system to brain, the potential protective role of mas receptors in COVID-19 infection |
EUROPEAN JOURNAL OF PHARMACOLOGY |
2023 |
